Clinical Course of Parotid Carcinoma with Hepatic and Nodal Metastases: A Case Report

Salivary gland tumors are relatively rare neoplasms, comprising approximately 3-6% of all head and neck tumors. Parotid gland carcinoma (PGC) represents approximately 70-80% of all salivary gland malignancies. Treatment strategies depend on tumor histology, stage, and molecular characteristics, with surgical resection and adjuvant radiotherapy being the mainstays of treatment for localized disease. Conversely, in advanced stages therapeutic approaches, including chemotherapy and targeted agents, are more challenging. We present a case report of a 60-year-old patient with hepatic and nodal metastases of parotid gland’s carcinoma, with the aim of highlighting the management and treatment outcomes.